![A cluster randomized trial of utilizing a local change team approach to improve the delivery of HIV services in correctional settings: study protocol A cluster randomized trial of utilizing a local change team approach to improve the delivery of HIV services in correctional settings: study protocol](https://scholarshare.temple.edu/bitstream/handle/20.500.12613/4194/A%20cluster%20randomized%20trial%20of%20utilizing%20a%20local%20change%20team%20approach%20to%20improve%20the%20delivery%20of%20HIV%20services%20in%20correctional.pdf.jpg?sequence=4&isAllowed=y)
A cluster randomized trial of utilizing a local change team approach to improve the delivery of HIV services in correctional settings: study protocol
![The STAR care pathway for patients with pain at 3 months after total knee replacement: a multicentre, pragmatic, randomised, controlled trial. The STAR care pathway for patients with pain at 3 months after total knee replacement: a multicentre, pragmatic, randomised, controlled trial.](https://eastmid.openrepository.com/bitstream/handle/20.500.12904/15213/The%20STAR%20care%20pathway%20for%20patients%20with%20pain%20at%203%20months%20after%20total%20knee%20replacement%20a%20multicentre%20pratmatic%20randomoised%20controlled%20trian.pdf.jpg?sequence=4&isAllowed=y)
The STAR care pathway for patients with pain at 3 months after total knee replacement: a multicentre, pragmatic, randomised, controlled trial.
![Didanosine alone or zidovudine plus didanosine was more effective thari zidovudine alon for children with HIV infection | BMJ Evidence-Based Medicine Didanosine alone or zidovudine plus didanosine was more effective thari zidovudine alon for children with HIV infection | BMJ Evidence-Based Medicine](https://ebm.bmj.com/content/3/1/15.extract.jpg)
Didanosine alone or zidovudine plus didanosine was more effective thari zidovudine alon for children with HIV infection | BMJ Evidence-Based Medicine
![Cancer patient survival can be parametrized to improve trial precision and reveal time-dependent therapeutic effects | Nature Communications Cancer patient survival can be parametrized to improve trial precision and reveal time-dependent therapeutic effects | Nature Communications](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41467-022-28410-9/MediaObjects/41467_2022_28410_Fig1_HTML.png)